TARELLA, Corrado

TARELLA, Corrado  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 177 (tempo di esecuzione: 0.037 secondi).
Titolo Data di pubblicazione Autore(i) File
A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results 2009 Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A
A pilot trial of G-CSF in amyotrophic lateral sclerosis 2008 Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C
A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept 2012 C.M. FRONTICELLI BALDELLI; M. RUELLA; S. SCUDERI; M. MONNI; R. PASSERA; P. OMEDE; C. TARELLA
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation. 1998 FERRERO D ;TARELLA C ;CHERASCO C ;BONDESAN P ;OMEDÈ P ;RAVAGLIA R ;CARACCIOLO D ;CASTELLINO C ;PILERI A
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. 2001 M. LADETTO; SAMETTI S; DONOVAN JW; FERRERO D; ASTOLFI M; MITTERER M; RICCA I; DRANDI D; CORRADINI P; COSER P; PILERI A; GRIBBEN JG; TARELLA C.
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups. 2013 Riva L; Ronchini C; Bodini M; Lo-Coco F; Lavorgna S; Ottone T; Martinelli G; Iacobucci I; Tarella C; Cignetti A; Volorio S; Bernard L; Russo A; Melloni GE; Luzi L; Alcalay M; Dellino GI; Pelicci PG
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 2016 Ruella, Marco; Filippi, Andrea Riccardo; Bruna, Riccardo; Di Russo, Anna; Magni, Michele; Caracciolo, Daniele; Passera, Roberto; Matteucci, Paola; Di Nicola, Massimo; Corradini, Paolo; Parvis, Guido; Gini, Guido; Olivieri, Attilio; Ladetto, Marco; Ricardi, Umberto; Tarella, Corrado; Devizzi, Liliana
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial 2007 GALLAMINI A; ZAJA F; PATTI C; BILLIO A; SPECCHIA MR; TUCCI A; LEVIS A; MANNA A; SECONDO V; RIGACCI L; PINTO A; IANNITTO E; ZOLI V; TORCHIO P; PILERI S; TARELLA C
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 2007 CORRADINI P; DODERO A; FARINA L; FANIN R; PATRIARCA F; MICELI R; MATTEUCCI P; BREGNI M; SCIMÈ R; NARNI F; POGLIANI E; LOCASCIULLI A; MILANI R; CARNITI C; BACIGALUPO A; RAMBALDI A; BONIFAZI F; OLIVIERI A; GIANNI AM; TARELLA C
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma. 1998 Majolino I; Corradini P; Scimè R; Santoro A; Tarella C; Cavallaro AM; Palumbo A; Indovina A; Caracciolo D; Boccadoro M; Marcenò R; Pileri A.
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. 1999 Boccadoro M; Tarella C; Palumbo A; Argentino C; Triolo S; Dominietto A; Callea V; Lauta VM; Molica S; Musto P; Marmont F; Gianni AM; Pileri A
Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation. 1997 Campana S; Corradini P; Astolfi M; Ladetto M; Cinque F; Novero D; Tarella C; Pileri A.
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders. 1986 Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E.
Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement. 1987 Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C; Pileri A; Rovera G; Mandelli F
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial. 2013 125. Zimmermann H; Choquet S; Moore J; Salles G; Morschhauser F; Lamy T; Jaccard A; Horst HA; Leithäuser M; Dührsen U; Reinke P; Lebranchu Y; Neuhaus R; Lehmkuhl H; Tarella C; Schlattmann P; Riess H; Leblond V.
Bone marrow transplantation for lymphoma CR1 2005 TARELLA C; GIANNI AM
Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy. 2013 Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C.
Both early and committed progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF. 1995 C. TARELLA; BENEDETTI G; CARACCIOLO D; CASTELLINO C; CHERASCO C; BONDESAN P; OMEDE' P; RUGGIERI D; GIANNI AM; PILERI A
CD34-positive cells: biology and clinical relevance. 1995 CARLO-STELLA C; CAZZOLA M; DE FABRITIIS P; DE VINCENTIIS A; GIANNI AM; LANZA F; LAURIA F; LEMOLI RM; C. TARELLA; ZANON P; TURA S.
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations 2006 LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C